160 related articles for article (PubMed ID: 20222173)
1. Clinical significance of Fas and FasL protein expression in gastric carcinoma and local lymph node tissues.
Li Q; Peng J; Li XH; Liu T; Liang QC; Zhang GY
World J Gastroenterol; 2010 Mar; 16(10):1274-8. PubMed ID: 20222173
[TBL] [Abstract][Full Text] [Related]
2. Significance of Fas and FasL protein expression in cardiac carcinoma and local lymph node tissues.
Li Y; Xu DF; Jiang D; Zhao J; Ge JF; Zheng SY
Int J Clin Exp Pathol; 2015; 8(9):11915-20. PubMed ID: 26617948
[TBL] [Abstract][Full Text] [Related]
3. Expression of Fas ligand in gastric carcinoma relates to lymph node metastasis.
Nagashima H; Mori M; Sadanaga N; Mashino K; Yoshikawa Y; Sugimachi K
Int J Oncol; 2001 Jun; 18(6):1157-62. PubMed ID: 11351245
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Fas/FasL expression to cell apoptosis in Epstein-Barr virus-associated gastric carcinoma.
He D; Xiao L; Chen JN; Liang Q; Shao CK
Chin J Cancer; 2010 Mar; 29(3):283-7. PubMed ID: 20193111
[TBL] [Abstract][Full Text] [Related]
5. [Expression of Fas, FasL and IFN-gamma in gastric cancer].
Li Z; Wang Z; Zhao Z; Zhang Y; Ke Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 35(4):386-9. PubMed ID: 12947554
[TBL] [Abstract][Full Text] [Related]
6. The distribution and intracellular location of Fas and Fas Ligand following gastric carcinogenesis: Fas Ligand expressing gastric carcinoma cells can inhibit local immune response.
Liu H; Ubukata H; Tabuchi T; Nakachi T; Nagata H; Shimazaki J; Motohashi G; Konishi S; Nishimura M; Satani T; Hong J; Nakada I; Saniabadi AR; Tabuchi T
Mol Cell Biochem; 2009 Nov; 331(1-2):181-6. PubMed ID: 19458913
[TBL] [Abstract][Full Text] [Related]
7. Correlation between Fas and FasL proteins expression in normal gastric mucosa and gastric cancer.
Gryko M; Guzińska-Ustymowicz K; Pryczynicz A; Cepowicz D; Kukliński A; Czyżewska J; Kemona A; Kędra B
Folia Histochem Cytobiol; 2011; 49(1):142-7. PubMed ID: 21526501
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of expression of apoptotic signal proteins in gastric carcinoma tissue.
Zhao XH; Gu SZ; Tian HG; Quan P; Pan BR
World J Gastroenterol; 2005 Jul; 11(25):3846-9. PubMed ID: 15991280
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas.
Takahama Y; Yamada Y; Emoto K; Fujimoto H; Takayama T; Ueno M; Uchida H; Hirao S; Mizuno T; Nakajima Y
Gastric Cancer; 2002; 5(2):61-8. PubMed ID: 12111580
[TBL] [Abstract][Full Text] [Related]
10. Expression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues.
Zhou D; Pan G; Zheng C; Zheng J; Yian L; Teng X
BMC Cancer; 2008 Nov; 8():353. PubMed ID: 19040718
[TBL] [Abstract][Full Text] [Related]
11. Effects of FasL expression in oral squamous cell cancer.
Fang L; Sun L; Hu FF; Chen QE
Asian Pac J Cancer Prev; 2013; 14(1):281-5. PubMed ID: 23534738
[TBL] [Abstract][Full Text] [Related]
12. Expression of Fas and Fas ligand in human gastric adenomas and intestinal-type carcinomas: correlation with proliferation and apoptosis.
Osaki M; Kase S; Kodani I; Watanabe M; Adachi H; Ito H
Gastric Cancer; 2001; 4(4):198-205. PubMed ID: 11846063
[TBL] [Abstract][Full Text] [Related]
13. Frequent expression of soluble Fas and Fas ligand in Chinese stomach cancer and its preneoplastic lesions.
Li H; Liu N; Guo L; Li JW; Liu J
Int J Mol Med; 2000 May; 5(5):473-6. PubMed ID: 10762649
[TBL] [Abstract][Full Text] [Related]
14. High Fas expression in gastric carcinoma cells as a factor correlating with the occurrence of metastases to regional lymph nodes.
Gryko M; Guzińska-Ustymowicz K; Kiśluk J; Cepowicz D; Kemona A; Kędra B
Adv Med Sci; 2014 Mar; 59(1):47-51. PubMed ID: 24797974
[TBL] [Abstract][Full Text] [Related]
15. Fas receptor (CD95) & Fas ligand (CD178) expression in patients with tobacco-related intraoral squamous cell carcinoma.
Das SN; Khare P; Singh MK; Sharma SC
Indian J Med Res; 2011 Jul; 134(1):54-60. PubMed ID: 21808135
[TBL] [Abstract][Full Text] [Related]
16. The extrinsic apoptotic signaling pathway in gastric adenocarcinomas assessed by tissue microarray.
Gomes TS; Oshima CT; Segreto HR; Barrazueta LM; Costa HO; Lima FO; Forones NM; Ribeiro DA
Pathol Res Pract; 2011 Oct; 207(10):613-7. PubMed ID: 21856093
[TBL] [Abstract][Full Text] [Related]
17. [Expression of metallothionein and FasL in colorectal cancer and its clinical significance].
Li SY; Yu B; An P; Zuo FY; Cai HY
Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1118-20. PubMed ID: 16194308
[TBL] [Abstract][Full Text] [Related]
18. Tight junction protein claudin 4 in gastric carcinoma and its relation to lymphangiogenic activity.
Shareef MM; Radi DM; Eid AM
Arab J Gastroenterol; 2015; 16(3-4):105-12. PubMed ID: 26526513
[TBL] [Abstract][Full Text] [Related]
19. Fas ligand expression in esophageal carcinomas and their lymph node metastases.
Younes M; Schwartz MR; Ertan A; Finnie D; Younes A
Cancer; 2000 Feb; 88(3):524-8. PubMed ID: 10649242
[TBL] [Abstract][Full Text] [Related]
20. The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer.
Sjöström-Mattson J; Von Boguslawski K; Bengtsson NO; Mjaaland I; Salmenkivi K; Blomqvist C
Acta Oncol; 2009; 48(8):1137-43. PubMed ID: 19863221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]